First published online July 6, 2005
Journal of Experimental Biology 208, 2765-2772 (2005)
Published by The Company of Biologists 2005
doi: 10.1242/jeb.01704
Cardioprotective effects of KATP channel activation during hypoxia in goldfish Carassius auratus
Jerri Chen,
Julia X. Zhu,
Ingred Wilson and
John S. Cameron*
Department of Biological Sciences, Wellesley College, Wellesley, MA
02481, USA

View larger version (173K):
[in a new window]
|
Fig. 1. Isolated ventricular myocytes from goldfish heart after exposure to 60 min
hypoxia in a solution containing Trypan Blue. Most cells retained the
elongated shape of those maintained under normoxic conditions, but some were
unable to exclude the dye (left), indicating cellular damage. Scale bar, 50
µm.
|
|

View larger version (12K):
[in a new window]
|
Fig. 2. Effects of moderate, substrate-free hypoxia on ventricular action potential
duration (APD) in the isolated goldfish heart. APD in hypoxia was
significantly shortened at 90% of full repolarization, but not at 50%
(N=5). Inset shows representative action potential configuration in
one experiment (normoxia at left). Values are means ± 1
S.E.M. **Significantly different from values
recorded under normoxic conditions (P<0.01).
|
|

View larger version (11K):
[in a new window]
|
Fig. 3. Effects of glibenclamide (5 µmol l1), a
KATP channel blocker, and L-NAME (50 µmol
l1), an inhibitor of nitric oxide synthase (NOS), on the
percentage change in action potential duration at 90% repolarization
(APD90) induced by hypoxia in goldfish ventricle (N=4).
Hypoxia-induced APD90 shortening was eliminated by simultaneous
exposure to either glibenclamide or L-NAME. Values are mean change
± 1 S.E.M.
|
|

View larger version (12K):
[in a new window]
|
Fig. 4. Effects of presumed KATP activators on the percentage change in
ventricular action potential duration (APD) under normoxic conditions.
APD90 was shortened by 10, 30 and 60 min exposure to SNAP (100
µmol l1), a nitric oxide (NO) donor (N=4), and
by 10 min exposure to 8-Br-cGMP (200 µmol l1), a stable
cGMP analog (N=6). Diazoxide (50 µmol l1), a
specific mitochondrial KATP (mitoKATP) channel opener,
did not significantly affect APD (N=6). Values shown are mean changes
± 1 S.E.M.
|
|

View larger version (8K):
[in a new window]
|
Fig. 5. Effect of 60 min hypoxia in vitro on the incidence of cell
staining by Trypan Blue. Under hypoxic conditions, a significantly greater
percentage of cells was unable to exclude the stain compared to that observed
in normoxia, suggesting cellular injury. A total of more than more than 500
myocytes were individually evaluated during six experiments; values are mean
changes ± 1 S.E.M. ***Significantly
different from values recorded in normoxia (P<0.001).
|
|

View larger version (20K):
[in a new window]
|
Fig. 6. Cardioprotective effect of SNAP (100 µmol l1) on the
hypoxia-induced damage incurred by isolated myocytes in vitro. Figs 6
and 7 show the percent change
in the total fraction of stained cells after 60 min hypoxia in the presence of
various agents, compared to that recorded after hypoxia alone. Under hypoxic
conditions, SNAP reduced the percentage of stained cells. In contrast,
L-NAME, which blocks hypoxia-induced synthesis of NO, increased the
percentage of stained cells when given alone, and eliminated the
cardioprotective influence of SNAP when the two drugs were administered
simultaneously.
|
|

View larger version (27K):
[in a new window]
|
Fig. 7. Cardioprotective influence of the mitoKATP opener diazoxide (50
µmol l1) and the stable cGMP analog 8-Br-cGMP (200
µmol l1) on the hypoxia-induced damage incurred by
isolated cells. This figure illustrates the percentage change in the total
fraction of stained cells after 60 min hypoxia in the presence of various
agents, compared to that recorded after hypoxia alone. Under hypoxic
conditions, both diazoxide and 8-Br-cGMP decreased the percentage of stained
cells vs that seen with hypoxia alone. Blockade of
mitoKATP channel activity with 5-HD (100 µmol
l1) reduced but did not eliminate the beneficial effect of
diazoxide, and did not affect the response to 8-Br-cGMP.
|
|
© The Company of Biologists Ltd 2005